83 related articles for article (PubMed ID: 9094256)
1. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
Bischoff A; Stickan-Verfürth M; Michel MC
Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
[TBL] [Abstract][Full Text] [Related]
2. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
Bell D; Millar BC; McDermott BJ
Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis.
Bischoff A; Rascher W; Michel MC
Am J Physiol; 1998 Oct; 275(4):F502-9. PubMed ID: 9755121
[TBL] [Abstract][Full Text] [Related]
4. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.
Bischoff A; Erdbrügger W; Smits J; Michel MC
J Physiol; 1996 Sep; 495 ( Pt 2)(Pt 2):525-34. PubMed ID: 8887762
[TBL] [Abstract][Full Text] [Related]
6. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
Sun XY; Edvinsson L; Hedner T
J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
[TBL] [Abstract][Full Text] [Related]
7. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
Sun XY; Dahlöf C; Edvinsson L; Hedner T
Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
[TBL] [Abstract][Full Text] [Related]
8. Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding.
Heilig M; Edvinsson L; Wahlestedt C
Eur J Pharmacol; 1991 Dec; 209(1-2):27-32. PubMed ID: 1667639
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effect of D-myo-inositol-1,2,6-trisphosphate (PP56) on neuropeptide Y-induced vasoconstriction in the feline dental pulp.
Kim SK; Ang L; Hsu YY; Dörscher-Kim J; Kim S
Arch Oral Biol; 1996; 41(8-9):791-8. PubMed ID: 9022916
[TBL] [Abstract][Full Text] [Related]
10. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
Pernow J; Modin A; Lundberg JM
Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog.
Potter EK; Edvinsson L; Gustafsson T
Eur J Pharmacol; 1992 Oct; 221(2-3):307-14. PubMed ID: 1426007
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin inhibits the natriuretic effects of neuropeptide Y in anesthetized rats.
Bischoff A; Limmroth V; Michel MC
J Pharmacol Exp Ther; 1998 Aug; 286(2):704-8. PubMed ID: 9694924
[TBL] [Abstract][Full Text] [Related]
13. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
Schwieler JH; Hjemdahl P
J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
[TBL] [Abstract][Full Text] [Related]
14. D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling?
Bell D; McDermott BJ
Gen Pharmacol; 1998 Nov; 31(5):689-96. PubMed ID: 9809464
[TBL] [Abstract][Full Text] [Related]
15. Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission.
Sun XY; Edvinsson L; Yoo H; Wahlestedt C; Hedner T
J Cardiovasc Pharmacol; 1995 May; 25(5):696-704. PubMed ID: 7630147
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of D-myo-inositol-1,2,6-trisphosphate on glucose-stimulated insulin secretion in the mouse.
Ahrén B
Neuropeptides; 1992 Mar; 21(3):163-6. PubMed ID: 1630602
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y-induced pressor responses in spontaneously hypertensive and Wistar-Kyoto rats antagonized by D-myo-inositol-1,2,6-triphosphate (PP56).
Sun XY; Edvinsson L; Hedner T
J Hypertens Suppl; 1991 Dec; 9(6):S344-5. PubMed ID: 1818993
[No Abstract] [Full Text] [Related]
18. Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats.
Sun XY; Feng QP; Zhao X; Edvinsson L; Hedner T
Life Sci; 1995; 57(12):1197-211. PubMed ID: 7674809
[TBL] [Abstract][Full Text] [Related]
19. Is PP56 (D-myo-inositol-1,2,6-trisphosphate) an antagonist at neuropeptide Y receptors?
Feth F; Erdbrügger W; Rascher W; Michel MC
Life Sci; 1993; 52(23):1835-44. PubMed ID: 8388981
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries.
Edvinsson L; Adamsson M; Jansen I
Neuropeptides; 1990 Oct; 17(2):99-105. PubMed ID: 2280824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
